adrenochrome has been researched along with Migraine Disorders in 10 studies
Adrenochrome: Pigment obtained by the oxidation of epinephrine.
Migraine Disorders: A class of disabling primary headache disorders, characterized by recurrent unilateral pulsatile headaches. The two major subtypes are common migraine (without aura) and classic migraine (with aura or neurological symptoms). (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1)
| Excerpt | Relevance | Reference |
|---|---|---|
| " The dosage was for Divascan 15 mg a day and for pizotifen 3 mg a day." | 2.64 | A comparison between placebo, pizotifen and 1-isopropyl-3-hydroxy-5-semicarbazono-6-oxo-2.3.5.6-tetrahydroindol (Divascan) in migraine prophylaxis. ( Osterman, PO, 1977) |
| "The knowledge of migraine pathogenesis is as yet insufficient for complete elucidation of its causes." | 1.30 | [Prophylactic treatment of migraine]. ( Kochanowski, J, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (60.00) | 18.7374 |
| 1990's | 4 (40.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wiedemann, M | 1 |
| de Lima, VM | 1 |
| Hanke, W | 1 |
| Koch, G | 1 |
| Kochanowski, J | 1 |
| Loebe, FM | 1 |
| Riethling, AK | 1 |
| Wiegershausen, B | 1 |
| Burian, R | 1 |
| Kangasniemi, P | 1 |
| Osterman, PO | 2 |
| Heydenreich, A | 1 |
| Thiessen, M | 1 |
3 trials available for adrenochrome and Migraine Disorders
| Article | Year |
|---|---|
Placebo, 1-isopropylnoradrenochrome-5-monosemicarbazono and pizotifen in migraine prophylaxis.
Topics: Adrenochrome; Adult; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle Age | 1979 |
A comparison between placebo, pizotifen and 1-isopropyl-3-hydroxy-5-semicarbazono-6-oxo-2.3.5.6-tetrahydroindol (Divascan) in migraine prophylaxis.
Topics: Adrenochrome; Adult; Body Weight; Clinical Trials as Topic; Drug Evaluation; Female; Humans; Indoleq | 1977 |
[Comparison of the effectiveness of drug therapy, invasive and non-invasive acupuncture in migraine].
Topics: Acupuncture Analgesia; Adrenochrome; Adult; Dihydroergotoxine; Electroacupuncture; Female; Follow-Up | 1989 |
7 other studies available for adrenochrome and Migraine Disorders
| Article | Year |
|---|---|
Effects of antimigraine drugs on retinal spreading depression.
Topics: Acetaminophen; Adrenergic beta-Antagonists; Adrenochrome; Analgesics, Non-Narcotic; Animals; Aspirin | 1996 |
[Side-effect free interval treatment of migraine. The serotonin antagonist iprazochrome].
Topics: Adrenochrome; Adult; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; | 1997 |
[Iprazochrome in migraine prevention. No concerns regarding longer-term administration].
Topics: Adrenochrome; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Indolequinones | 1997 |
[Prophylactic treatment of migraine].
Topics: Adrenergic alpha-Antagonists; Adrenochrome; Dopamine Antagonists; Homeopathy; Humans; Indolequinones | 1999 |
[Migraine prophylaxis with the new serotonin antagonist Divascan].
Topics: Adrenochrome; Animals; Chlordiazepoxide; Dose-Response Relationship, Drug; Drug Therapy, Combination | 1975 |
[The effectiveness of the serotonin antagonist Divascan in migraine therapy].
Topics: Adrenochrome; Drug Evaluation; Humans; Migraine Disorders | 1975 |
Divascan in migraine prophylaxis. Open trial with three different doses.
Topics: Adrenochrome; Dose-Response Relationship, Drug; Humans; Indolequinones; Migraine Disorders; Semicarb | 1978 |